VISIATIV SA (ALVIV.PA) Fundamental Analysis & Valuation

EPA:ALVIV • FR0004029478

Current stock price

37 EUR
+0.1 (+0.27%)
Last:

This ALVIV.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. ALVIV.PA Profitability Analysis

1.1 Basic Checks

  • ALVIV had positive earnings in the past year.
  • In the past year ALVIV had a positive cash flow from operations.
  • ALVIV had positive earnings in each of the past 5 years.
  • Each year in the past 5 years ALVIV had a positive operating cash flow.
ALVIV.PA Yearly Net Income VS EBIT VS OCF VS FCFALVIV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M 20M 25M

1.2 Ratios

  • The Return On Assets of ALVIV (2.85%) is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of 13.14%, ALVIV is in the better half of the industry, outperforming 60.32% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 6.92%, ALVIV is in line with its industry, outperforming 42.86% of the companies in the same industry.
  • ALVIV had an Average Return On Invested Capital over the past 3 years of 7.35%. This is significantly below the industry average of 12.44%.
Industry RankSector Rank
ROA 2.85%
ROE 13.14%
ROIC 6.92%
ROA(3y)3.27%
ROA(5y)2.33%
ROE(3y)15.28%
ROE(5y)11.1%
ROIC(3y)7.35%
ROIC(5y)6.7%
ALVIV.PA Yearly ROA, ROE, ROICALVIV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.60%, ALVIV is in line with its industry, outperforming 58.73% of the companies in the same industry.
  • ALVIV's Profit Margin has improved in the last couple of years.
  • With a Operating Margin value of 6.23%, ALVIV perfoms like the industry average, outperforming 49.21% of the companies in the same industry.
  • ALVIV's Operating Margin has improved in the last couple of years.
  • ALVIV has a Gross Margin (70.23%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of ALVIV has grown nicely.
Industry RankSector Rank
OM 6.23%
PM (TTM) 3.6%
GM 70.23%
OM growth 3Y17.05%
OM growth 5Y2.75%
PM growth 3Y67.21%
PM growth 5Y12.34%
GM growth 3Y1.22%
GM growth 5Y1.82%
ALVIV.PA Yearly Profit, Operating, Gross MarginsALVIV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ALVIV.PA Health Analysis

2.1 Basic Checks

  • ALVIV has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for ALVIV has been increased compared to 1 year ago.
  • ALVIV has a better debt/assets ratio than last year.
ALVIV.PA Yearly Shares OutstandingALVIV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
ALVIV.PA Yearly Total Debt VS Total AssetsALVIV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

  • ALVIV has an Altman-Z score of 1.52. This is a bad value and indicates that ALVIV is not financially healthy and even has some risk of bankruptcy.
  • ALVIV's Altman-Z score of 1.52 is on the low side compared to the rest of the industry. ALVIV is outperformed by 69.84% of its industry peers.
  • ALVIV has a Debt/Equity ratio of 1.22. This is a high value indicating a heavy dependency on external financing.
  • ALVIV has a Debt to Equity ratio of 1.22. This is in the lower half of the industry: ALVIV underperforms 79.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Altman-Z 1.52
ROIC/WACC1.1
WACC6.31%
ALVIV.PA Yearly LT Debt VS Equity VS FCFALVIV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

  • ALVIV has a Current Ratio of 1.13. This is a normal value and indicates that ALVIV is financially healthy and should not expect problems in meeting its short term obligations.
  • ALVIV has a Current ratio (1.13) which is in line with its industry peers.
  • ALVIV has a Quick Ratio of 1.13. This is a normal value and indicates that ALVIV is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.13, ALVIV perfoms like the industry average, outperforming 46.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13
ALVIV.PA Yearly Current Assets VS Current LiabilitesALVIV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ALVIV.PA Growth Analysis

3.1 Past

  • The earnings per share for ALVIV have decreased strongly by -12.29% in the last year.
  • Measured over the past years, ALVIV shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.66% on average per year.
  • ALVIV shows a small growth in Revenue. In the last year, the Revenue has grown by 7.23%.
  • Measured over the past years, ALVIV shows a quite strong growth in Revenue. The Revenue has been growing by 11.20% on average per year.
EPS 1Y (TTM)-12.29%
EPS 3Y79.02%
EPS 5Y21.66%
EPS Q2Q%-35.61%
Revenue 1Y (TTM)7.23%
Revenue growth 3Y13.47%
Revenue growth 5Y11.2%
Sales Q2Q%4.38%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.46% on average over the next years. This is quite good.
  • Based on estimates for the next years, ALVIV will show a small growth in Revenue. The Revenue will grow by 6.74% on average per year.
EPS Next Y-12.18%
EPS Next 2Y4.17%
EPS Next 3Y9.46%
EPS Next 5YN/A
Revenue Next Year6.94%
Revenue Next 2Y7.05%
Revenue Next 3Y6.74%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALVIV.PA Yearly Revenue VS EstimatesALVIV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
ALVIV.PA Yearly EPS VS EstimatesALVIV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

3

4. ALVIV.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALVIV is valuated rather expensively with a Price/Earnings ratio of 17.05.
  • Based on the Price/Earnings ratio, ALVIV is valued a bit cheaper than 68.25% of the companies in the same industry.
  • ALVIV's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.78.
  • With a Price/Forward Earnings ratio of 17.63, ALVIV is valued on the expensive side.
  • The rest of the industry has a similar Price/Forward Earnings ratio as ALVIV.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.54, ALVIV is valued a bit cheaper.
Industry RankSector Rank
PE 17.05
Fwd PE 17.63
ALVIV.PA Price Earnings VS Forward Price EarningsALVIV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALVIV is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.52
ALVIV.PA Per share dataALVIV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • The decent profitability rating of ALVIV may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.79
EPS Next 2Y4.17%
EPS Next 3Y9.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. ALVIV.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 5.02%, ALVIV is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.76, ALVIV pays a better dividend. On top of this ALVIV pays more dividend than 87.30% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, ALVIV pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.02%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
ALVIV.PA Yearly Dividends per shareALVIV.PA Yearly Dividends per shareYearly Dividends per share 2022 2023 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • ALVIV pays out 50.00% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP50%
EPS Next 2Y4.17%
EPS Next 3Y9.46%
ALVIV.PA Yearly Income VS Free CF VS DividendALVIV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M
ALVIV.PA Dividend Payout.ALVIV.PA Dividend Payout, showing the Payout Ratio.ALVIV.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ALVIV.PA Fundamentals: All Metrics, Ratios and Statistics

VISIATIV SA

EPA:ALVIV (8/14/2024, 7:00:00 PM)

37

+0.1 (+0.27%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)07-24
Earnings (Next)10-22
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap169.90M
Revenue(TTM)277.50M
Net Income(TTM)10.00M
Analysts44.44
Price Target37.4 (1.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.02%
Yearly Dividend1.11
Dividend Growth(5Y)N/A
DP50%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.49%
EPS NY rev (3m)-6.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.08%
Valuation
Industry RankSector Rank
PE 17.05
Fwd PE 17.63
P/S 0.61
P/FCF N/A
P/OCF 12.87
P/B 2.23
P/tB N/A
EV/EBITDA 8.52
EPS(TTM)2.17
EY5.86%
EPS(NY)2.1
Fwd EY5.67%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)2.87
OCFY7.77%
SpS60.43
BVpS16.57
TBVpS-17.73
PEG (NY)N/A
PEG (5Y)0.79
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 2.85%
ROE 13.14%
ROCE 9.14%
ROIC 6.92%
ROICexc 9.72%
ROICexgc N/A
OM 6.23%
PM (TTM) 3.6%
GM 70.23%
FCFM N/A
ROA(3y)3.27%
ROA(5y)2.33%
ROE(3y)15.28%
ROE(5y)11.1%
ROIC(3y)7.35%
ROIC(5y)6.7%
ROICexc(3y)11.38%
ROICexc(5y)10.34%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.71%
ROCE(5y)8.86%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y11.15%
ROICexc growth 5Y-0.43%
OM growth 3Y17.05%
OM growth 5Y2.75%
PM growth 3Y67.21%
PM growth 5Y12.34%
GM growth 3Y1.22%
GM growth 5Y1.82%
F-Score5
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Debt/EBITDA 3.44
Cap/Depr 140.63%
Cap/Sales 4.86%
Interest Coverage 250
Cash Conversion 49.07%
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z 1.52
F-Score5
WACC6.31%
ROIC/WACC1.1
Cap/Depr(3y)146%
Cap/Depr(5y)132.7%
Cap/Sales(3y)4.96%
Cap/Sales(5y)4.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.29%
EPS 3Y79.02%
EPS 5Y21.66%
EPS Q2Q%-35.61%
EPS Next Y-12.18%
EPS Next 2Y4.17%
EPS Next 3Y9.46%
EPS Next 5YN/A
Revenue 1Y (TTM)7.23%
Revenue growth 3Y13.47%
Revenue growth 5Y11.2%
Sales Q2Q%4.38%
Revenue Next Year6.94%
Revenue Next 2Y7.05%
Revenue Next 3Y6.74%
Revenue Next 5YN/A
EBIT growth 1Y-8.95%
EBIT growth 3Y32.82%
EBIT growth 5Y14.26%
EBIT Next Year64.27%
EBIT Next 3Y21.88%
EBIT Next 5YN/A
FCF growth 1Y-104.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.87%
OCF growth 3Y-2.92%
OCF growth 5Y11.59%

VISIATIV SA / ALVIV.PA Fundamental Analysis FAQ

What is the fundamental rating for ALVIV stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALVIV.PA.


What is the valuation status for ALVIV stock?

ChartMill assigns a valuation rating of 2 / 10 to VISIATIV SA (ALVIV.PA). This can be considered as Overvalued.


How profitable is VISIATIV SA (ALVIV.PA) stock?

VISIATIV SA (ALVIV.PA) has a profitability rating of 6 / 10.


What are the PE and PB ratios of VISIATIV SA (ALVIV.PA) stock?

The Price/Earnings (PE) ratio for VISIATIV SA (ALVIV.PA) is 17.05 and the Price/Book (PB) ratio is 2.23.


What is the financial health of VISIATIV SA (ALVIV.PA) stock?

The financial health rating of VISIATIV SA (ALVIV.PA) is 2 / 10.